Source: Annual Congress 2011 - Diagnosis and treatment of inflammatory respiratory diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. Sekiya, M. Taniguchi, H. Tanimoto, K. Akiyama (Kanagawa, Japan). Age-specific background in inpatients with severe asthma exacerbation. Eur Respir J 2011; 38: Suppl. 55, 4082

Member's Comments

No comment yet.

Related content which might interest you: Continuous objective assessment of wheezing in adult asthma patients hospitalised following an acute exacerbation of asthma Source: Eur Respir J 2001; 18: Suppl. 33, 267s Year: 2001 Effect of β2-agonists on severe asthma exacerbation and asthma-related hospitalization Source: Eur Respir J 2007; 30: Suppl. 51, 352s Year: 2007 Predictors of severe exacerbations in patients with moderate and severe asthma Source: International Congress 2018 – Determinants and monitoring of asthma control Year: 2018 Physiological impairments and exacerbation risk in COPD patients with less symptom and no frequent exacerbation history. Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD Year: 2021 Relationship between benralizumab exposure and asthma exacerbation rate for patients with severe asthma Source: International Congress 2017 – Asthma: mechanisms and treatment Year: 2017 Incidence of asthma and COPD in a general population Source: Annual Congress 2010 - Prevalence and incidence of asthma and COPD Year: 2010 Predictors of mortality in COPD patients after hospitalization due to an exacerbation Source: International Congress 2019 – Exacerbations of airway diseases Year: 2019 Predictors of mortality in COPD during acute exacerbation Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment Year: 2009 Trends in the lifetime risk of COPD exacerbation requiring hospitalisation Source: Eur Respir J 2013; 42: 964-971 Year: 2013 Risk factors for severe exacerbations in a real-life population of adults with severe refractory asthma Source: International Congress 2017 – Many faces of asthma and allergies Year: 2017 Impact of COVID-19 side-effects on pediatric and adult patients with recurrent wheeze and asthma Source: Virtual Congress 2021 – Paediatric allergic asthma: novel therapeutics and monitoring approaches Year: 2021 Quantification of severity of the acute exacerbation in hospitalized COPD patients Source: Eur Respir J 2003; 22: Suppl. 45, 559s Year: 2003 One-year mortality in COPD patients after severe exacerbation Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016 Frequency and clinical characteristics of rapid-onset fatal and near-fatal asthma Source: Eur Respir J 2002; 19: 846-852 Year: 2002 Predicting frequent exacerbations in a severe asthma centre. Source: Virtual Congress 2020 – New tools for diagnosis of obstructive diseases Year: 2020 Comparing the prevalence of depression and anxiety in patients admitted with an exacerbation of COPD using two scoring systems Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations Year: 2015 Incidence of COPD and asthma overlap Source: Annual Congress 2009 - Asthma assessment and original therapeutic approaches Year: 2009 Are we routinely using severity assessment in hospital admissions with acute severe asthma? Source: Annual Congress 2008 - Severe asthma: a heterogeneous clinical entity Year: 2008 Risk factors for another hospitalization in COPD patients hospitalized for exacerbation Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases Year: 2016 COPD patients with asthma, characteristics and risk of exacerbations Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019